The gene set enrichment analysis suggested that these genes are statistically enriched in many cancer signalling pathways, such as p53 signalling, pancreatic adenocarcinoma signalling, and prostate cancer signalling. This evidence concerns the gene TP53 and Familial prostate cancer.